This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Alastair Hay
Vice President Peptides at Almac


Having trained as a PhD in Synthetic Organic Chemistry, Alastair has been with Almac since 2002. He has worked in various roles, starting on developing novel purification methods for peptides, and moving through a series of management roles in Custom synthesis and Process Development.

From 2016, Alastair headed Almac’s Business Development activities, providing support to Almac’s API services global Business Development team for peptide projects.

In September 2021, Alastair was appointed Vice President Peptides, with responsibility for all aspects of Almac’s peptide business.

Agenda Sessions

  • Transitioning Peptide Therapeutic Research Programmes to Clinical Development